PHAT vs UNP · rev $132.6M vs P/E 21, rev $6.86B
Phathom Pharmaceuticals Inc (PHAT) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
PHAT currently screens at market cap $622.7M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the PHAT and UNP stock pages for the full models.
Not investment advice.